Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 26, 2022 01:00 ET | Source: VALNEVA

Valneva et Pfizer annoncent des données pédiatriques positives de Phase 2 pour leur candidat vaccin contre la maladie de Lyme

Très bon profil d'immunogénicité observé chez les participants âgés de 5 à 17 ans, un mois après le schéma de primo-vaccinationProfil d’innocuité observé chez les participants pédiatriques similaire...
April 26, 2022 01:00 ET | Source: VALNEVA

Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate

Strong immunogenicity profile observed in study participants aged 5-17 years one month after the primary vaccination seriesSafety profile observed in pediatric participants similar to previously...
April 25, 2022 21:00 ET | Source: Advantest America, Inc.

Advantest ACS Nexus Enables Real-time Data Analytics for Semiconductor Test

Highlights: New ACS Nexus enables real-time data streaming from distributed test floors across the semiconductor supply chain for the analytics solutions of customers and third-parties Strategic...
April 25, 2022 19:28 ET | Source: Norwall PowerSystems

Generac Product Line Updates at Norwall

United States, Arizona, Lake Havasu City, April 25, 2022 (GLOBE NEWSWIRE) -- 2022 Generac Generator Line Reflects Consumer Demand for Backup Power Products As Norwall heads into the third year...
April 25, 2022 17:05 ET | Source: Transocean Ltd.

Transocean Ltd. Provides Quarterly Fleet Status Report

STEINHAUSEN, Switzerland, April 25, 2022 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) today issued a quarterly Fleet Status Report that provides the current status of, and contract information...
April 25, 2022 17:05 ET | Source: Barrick Gold Corporation

Holistic Approach to ESG Will Make Lasting Impact, Says Barrick

All amounts expressed in US dollars TORONTO, April 25, 2022 (GLOBE NEWSWIRE) -- Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) has an integrated approach to sustainability to address each of the...
April 25, 2022 16:42 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, April 25, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research...
April 25, 2022 16:32 ET | Source: Freddie Mac

Freddie Mac Issues Monthly Volume Summary for March 2022

MCLEAN, Va., April 25, 2022 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today posted to its website its Monthly Volume Summary for March 2022, which provides information on Freddie Mac’s...
April 25, 2022 16:30 ET | Source: Transcontinental inc.

TC Transcontinental cesse la distribution du Publisac à Mirabel

MONTRÉAL, 25 avr. 2022 (GLOBE NEWSWIRE) -- À la suite de la décision de la Cour supérieure, rendue le 20 avril 2022, rejetant sa requête en nullité du règlement de la Ville de Mirabel sur la...
April 25, 2022 16:30 ET | Source: Transcontinental Inc.

TC Transcontinental Stops the Distribution of Publisac in Mirabel

MONTRÉAL, April 25, 2022 (GLOBE NEWSWIRE) -- Following the Superior Court's decision, rendered on April 20, 2022, dismissing its motion to nullify the City of Mirabel’s by-law on the...